An in-depth look to GENETETHER THERAPEUTICS INC. operating, investing, and financing activities

GTTX free cash flow for Q3 24 is -107.32 k CAD. For 2023, GTTX free cash flow was -627.41 k CAD and operating cash flow was -627.41 k CAD.